Lower Gastrointestinal Bleeding Because of Kasabach-Merritt Syndrome Showing an Impressive Response to Sirolimus

Jorge Sandelis Pérez1, Dahima Cintrón2, Alexandra Deyá-Quinquilla3

  • 1Internal Medicine Department, University of Puerto Rico-Medical Sciences Campus, San Juan, Puerto Rico.

Insights

Kasabach-Merritt syndrome, a rare vascular tumor complication, typically affects children. This case highlights successful sirolimus treatment in an adult with severe gastrointestinal bleeding from this condition.

Area of Science:

  • Vascular biology
  • Pediatric oncology
  • Hematology

Background:

  • Kasabach-Merritt syndrome (KMS) is a rare, life-threatening condition characterized by vascular tumors causing coagulopathy.
  • KMS typically presents in infants and young children with complications like thrombocytopenia and hemolytic anemia.

Observation:

  • This report details an adult patient experiencing recurrent, severe lower gastrointestinal bleeding.
  • The bleeding was attributed to Kasabach-Merritt syndrome, a presentation uncommon in adults.

Findings:

  • The adult patient with KMS and severe gastrointestinal bleeding was treated with sirolimus.
  • Sirolimus therapy proved successful in managing the bleeding and associated coagulopathy.

Implications:

  • This case expands the known clinical spectrum of Kasabach-Merritt syndrome to include adult presentations.
  • Sirolimus represents a potential therapeutic option for adult KMS patients, particularly those with refractory bleeding.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
130
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
232
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
200